Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 266-269
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.266
Prognostic impact of preoperative nutritional and immune inflammatory parameters on liver cancer
Sung Uk Bae
Sung Uk Bae, Department of Surgery, School of Medicine, Dongsan Medical Center, Keimyung University, Daegu KS002, South Korea
Author contributions: Bae SU designed research; Bae SU performed research; Bae SU analyzed data; Bae SU wrote the letter; and Bae SU revised the letter.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sung Uk Bae, Doctor, MD, PhD, Associate Professor, Doctor, Department of Surgery, School of Medicine, Dongsan Medical Center, Keimyung University, 1035, Dalgubeol-daero, Dalseo-gu, Daegu KS002, South Korea. sabiston0000@hanmail.net
Received: November 21, 2023
Peer-review started: November 21, 2023
First decision: December 17, 2023
Revised: January 2, 2024
Accepted: January 29, 2024
Article in press: January 29, 2024
Published online: February 27, 2024
Core Tip

Core Tip: In this issue of the World Journal of Gastrointestinal Surgery, they examined the prognosis of liver cancer radical resection in relation to the preoperative systemic immune-inflammation and geriatric nutritional risk indices. They provided further evidence for the significance of nutritional and immune-inflammatory biomarkers in patients undergoing hepatocellular carcinoma treatment.